SCHEMBL6960622

SCHEMBL6960622

O=c1oc(-c2ccccc2)cc(O)c1SCCc1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 7/20 0.49
L3MBTL1 Q9Y468 2/20 0.49
POLB P06746 1/20 0.49
ABCB1 P08183 8/20 0.42
MAPT P10636 6/20 0.42
MEN1 O00255 5/20 0.42
KMT2A Q03164 5/20 0.42
CYP1B1 Q16678 5/20 0.42
TP53 P04637 5/20 0.42
CYP3A4 P08684 5/20 0.42
HPGD P15428 5/20 0.42
ALOX15 P16050 4/20 0.42
CYP1A2 P05177 4/20 0.42
FTO Q9C0B1 4/20 0.42
KDM4E B2RXH2 4/20 0.42
ALDH1A1 P00352 4/20 0.42
HSD17B10 Q99714 4/20 0.42
CYP1A1 P04798 3/20 0.42
XDH P47989 3/20 0.42
GABRP O00591 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6954657 0.95 SMN1; SMN2 (0.44) SMN1; SMN2L3MBTL1POLBABCB1MAPT
SCHEMBL6956148 0.93 PTGES (0.45) SMN1; SMN2L3MBTL1POLBABCB1MAPT
SCHEMBL6963458 0.93 SMN1; SMN2 (0.46) SMN1; SMN2L3MBTL1POLBABCB1MAPT
SCHEMBL6959678 0.92 SMN1; SMN2 (0.42) SMN1; SMN2L3MBTL1POLBABCB1MAPT
SCHEMBL6964030 0.92 SMN1; SMN2 (0.45) SMN1; SMN2L3MBTL1POLBABCB1MAPT
SCHEMBL6950945 0.91 GSK3B (0.47) SMN1; SMN2L3MBTL1POLBMEN1KMT2A
SCHEMBL6964247 0.91 AR (0.42) SMN1; SMN2L3MBTL1POLBABCB1MEN1
SCHEMBL6956056 0.90 TNKS (0.47) SMN1; SMN2L3MBTL1POLBABCB1HPGD
SCHEMBL6960159 0.90 SMN1; SMN2 (0.40) SMN1; SMN2L3MBTL1POLBABCB1MAPT
SCHEMBL6959999 0.89 NTRK1 (0.46) SMN1; SMN2L3MBTL1POLBABCB1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0729465-B1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE DAVIS & CO (US) 2003-01-22 EP disclosed
US-6005103-A TREATMENT OF BACTERIAL AND VIRAL INFECTIONS AND DISEASES, INCLUDING AIDS WARNER-LAMBERT COMPANY (US) 1999-12-21 US disclosed
US-5808062-A AIDS THERAPY WARNER-LAMBERT COMPANY (US) 1998-09-15 US disclosed
EP-0729465-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
WO-1995014013-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed